Paskett Presents Jimmie Holland Lecture at National Alliance Meeting  

Share this news item:

Contact Us

For media inquiries:
614-293-3737

To find a doctor, get a referral or for information on a clinical trial:
614-293-5066
or 800-293-5066

Search for a clinical trial

Posted: 7/2/2012

​Electra Paskett​Electra Paskett
COLUMBUS, Ohio – Ohio State University cancer researcher Electra Paskett (43017) presented the 12th annual Jimmie Holland lecture during the recent Alliance for Clinical Trials in Oncology meeting in Chicago.
 
Paskett, who is the associate director for population sciences at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), and holds the Marion N. Rowley Chair in Cancer Research at Ohio State, presented “Interventions to Address Cancer Health Disparities:  The Case of Cervical Cancer in Appalachia.”
 
According to the National Institutes of Health, health disparities are defined as “differences in the incidence, prevalence, mortality, and burden of diseases & other adverse health conditions that exist among specific population groups in the United States.”
 
As part of her lecture, Paskett discussed methods to eliminate cancer health disparities including conducting community based participatory research with trans-disciplinary teams using multi-level interventions. She also reviewed the goal and past and current research projects in the Ohio State University Center for Population Health and Health Disparities that she leads in Appalachia Ohio. This center seeks to understand why Appalachian Ohio women have high incidence and mortality rates for cervical cancer and uses a transdisciplinary research team to examine and intervene on the causes of this disparity.
 
“Dr. Paskett’s prolific work in intervention research directed at cancer prevention, early detection and survivorship issues, specifically among underserved populations, has helped transform cooperative group research in this area,” said Dr. Monica M. Bertagnolli, chief of surgical oncology at Dana-Farber/Brigham and Women's Cancer Center and group chair of the Alliance for Clinical Trials in Oncology. “She exemplifies the legacy of Jimmie Holland who has championed survivorship research and helped patients improve their quality of life after cancer diagnosis and treatment.”
 
The Jimmie Holland lecture, sponsored by the Health Outcomes Committee of the Alliance for Clinical Trials in Oncology, is named for Dr. Jimmie C. Holland, Wayne E. Chapman chair in psychiatric oncology at Memorial Sloan-Kettering Cancer Center. Over the years, Holland has pioneered ways in which counseling, psychosocial interventions, and medications can reduce the distress experienced by cancer patients and their families.
 
Paskett is a past president of the American Society of Preventive Oncology, a national society that promotes cancer prevention and control research. She is co-leader of the Cancer Control Program at Ohio State’s Comprehensive Cancer Center, and is a professor in both Ohio State’s College of Medicine and College of Public Health.
 
The Alliance for Clinical Trials in Oncology, a new cancer clinical trials cooperative group formed by merging three other cooperative groups, is a nationwide clinical research community sponsored by the National Cancer Institute.
 
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report. 
 
# # #
 
Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu




Tags: Prevention Research; Researchers; Preventive; James Cancer Hospital; OSU College of Medicine; OSU Medical Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu